Session » Sjögren's Syndrome - Poster II: Clinical Science

Date: Tuesday, November 15, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2663

Antimalarials Protect Against Damage Accrual in Primary SjöGren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2669

Biological Treatments in Primary SjöGren Syndrome

9:00AM-11:00AM: Abstract Number: 2676

Changes in Salivary Gland Echostructure in Patients with Primary SjöGren’s Syndrome over the Time: A Four-Year Longitudinal Study

9:00AM-11:00AM: Abstract Number: 2688

Characteristics, Treatment and Outcome of Joint Involvement with Synovitis in Primary SjöGren’s Syndrome: French Multicentric Retrospective Case-Control Study

9:00AM-11:00AM: Abstract Number: 2681

Clinical and Immunological Characteristics of Primary Sjogren´s Syndrome in Men

9:00AM-11:00AM: Abstract Number: 2677

Clinical Features of Primary Sjogren’s Syndrome Associated Lung Involvement with Extro-Glandular Manifestations at Onset

9:00AM-11:00AM: Abstract Number: 2691

Clinical, Radiological and Functional Characteristics of Clinically Significant Pulmonary Involvement in Primary SjöGren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2679

Clinically Meaningful Improvement of Essdai and Esspri in Patients with Primary SjöGren’s Syndrome in Real Life: A 12-Month Longitudinal Study

9:00AM-11:00AM: Abstract Number: 2689

Comparison of the 2016 ACR/EULAR and the 2002 AECG Classification Criteria in a Cohort of Patients with Suspected Primary SjöGren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2690

Detection of Dorsal Root Ganglionitis with Magnetic Resonance Neurography in Sensory Ataxic Neuropathy Associated with SjöGren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2680

Determinants of Fatigue in Patients with Primary SjöGren’s Syndrome and Impact of Fatigue on Patients’ Treatments: A Cohort Study

9:00AM-11:00AM: Abstract Number: 2684

Diagnosis of Systemic Diseases in Patients Presenting with Sicca Syndrome Using a Minimally-Invasive Minor Salivary Gland Biopsy: Analysis of 901 Patients

9:00AM-11:00AM: Abstract Number: 2660

Do Ultrasonographic Lesions of Salivary Glands Evolve in SjöGren Patients during Follow-up ?

9:00AM-11:00AM: Abstract Number: 2662

Effect of Tobacco Smoking on the Clinical, Histopathological, and Serological Manifestations of SjöGren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2672

Elderly Patients Risk a False Positive Diagnosis of Primary Sjogren’s Syndrome If a Positive Labial Gland Biopsy Is Solely Based on Focus Score

9:00AM-11:00AM: Abstract Number: 2665

Epratuzumab Treatment of Patients with Systemic Lupus Erythematosus and Secondary Sjogren’s Syndrome: An Exploratory Analysis of Phase 3 Studies

9:00AM-11:00AM: Abstract Number: 2675

Essdai, Clinessdai and DAS Scoring at Diagnosis of Primary Sjogren Syndrome: Association with the Development of Hematologic and Solid Neoplasias in 1301 Patients

9:00AM-11:00AM: Abstract Number: 2678

EULAR Primary SjöGren’s Syndrome Disease Activity Index (ESSDAI), Results from the National Registry of the Spanish Society of Rheumatology (SJÖGRENSER)

9:00AM-11:00AM: Abstract Number: 2664

Evaluation of Thyroid Autoimmune Disease in Primary SjöGren’s Syndrome and Its Association with Disease Phenotype

9:00AM-11:00AM: Abstract Number: 2693

Evolution of Disease Activity over a 5-Year Period in the 395 Patients with Primary SjöGren’s Syndrome of the Assess Prospective Cohort

9:00AM-11:00AM: Abstract Number: 2673

Glandular Ultrasonography in Primary SjöGren Syndrome: Clinical and Laboratory Correlation

9:00AM-11:00AM: Abstract Number: 2682

How Does Primary Sjogren Syndrome Present in Biopsy-Proven Patients without Circulating Ro/La Autoantibodies? Characteristics at Diagnosis of 2073 Patients from the SjöGren Big Data Project

9:00AM-11:00AM: Abstract Number: 2671

Impaired Bone Health in Patients with Primary Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2683

Isolated Anti-La/SS-B Positivity in Patients Diagnosed with Primary Sjogren Syndrome: Analysis of 222 Patients from the Sjogren Big Data Cohort

9:00AM-11:00AM: Abstract Number: 2686

Objective Improvement in Fatigue Scores for Primary Sjögren’s Patients Receiving a Tailored Multidisciplinary Fatigue Intervention in a Generic Fatigue Clinic

9:00AM-11:00AM: Abstract Number: 2661

Performance of the Proposed ACR-EULAR Criteria for Sjogren’s Syndrome in a Prospective Multidisciplinary Diagnostic Cohort from Daily Clinical Practice

9:00AM-11:00AM: Abstract Number: 2687

Prevalence of Abortions and Fetal Atrioventricular Block in Patients with Positive ANTI-RO and ANTI-La Antibodies

9:00AM-11:00AM: Abstract Number: 2674

Primary Sjögren’s Syndrome: Extraglandular Manifestations and Hydroxychloroquine Therapy

9:00AM-11:00AM: Abstract Number: 2692

Pulmonary Involvement, As Part of the Essdai, in Primary Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2668

Real Time Sonoelastography in Primary Sjögren’s Syndrome Correlates with Morphological Ultrasonographic Features and Glandular Activity but Not with Glandular Fibrosis

9:00AM-11:00AM: Abstract Number: 2659

Respiratory Symptoms in Patients with Primary SjöGren’s Syndrome – a Case-Control Study

9:00AM-11:00AM: Abstract Number: 2666

Therapeutic Efficacy of Iguratimod in Patients with Primary Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2685

Ultrasound of the Major Salivary Glands Is a Reliable Imaging Technique for Diagnosing Patients Clinically Suspected with SjöGren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2667

Whole Frequency Audiometrical Correlation with Disease Activity in Primary SjöGren’s Syndrome in Hispanic Population

9:00AM-11:00AM: Abstract Number: 2670

Work Disability in Newly Diagnosed Patients with Primary SjöGren’s Syndrome – a Population-Based Cohort Study

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].